LQDA Liquidia Corp

NEUTRAL Impact: 4/10 Insider Cluster (2 insiders)
Horizon days Filed May 26, 2026 Processed 17d 12h ago
Insider cluster: 2 insiders, $1.8M total
Latest settled — T+5d
LQDA ▼ -10.22% at T+5d
NEUTRAL call ✗ call lost -10.22% · α vs SPY -10.69% · entry $62.03 → $55.69
Next anchor: T+20d in 11d
Currently $71.23 · +14.83% from $62.03 entry
Entry anchored
May 26, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.55%
$62.03
settled 17d ago
T+5d
-10.22%
call -10.22% · α -10.69%
$55.69
settled 11d ago
T+20d
call — · α —
in 11d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Roger Jeffs sold 100,000 shares (~$6.1M) over four consecutive trading days, and director/10% owner Caligan Partners LP sold 5,300 shares (~$318K) in the same window. Total insider sales of ~$6.4M represent 0.12% of LQDA's $5.4B market cap, a modest amount. Insider sales are typically a weak directional signal, and the size relative to market cap is not alarming.

Key Financial Metrics

Direction
selling
Total Value
$6.4M
Insiders
2

Actionable Insight

Insider selling is modest relative to market cap and not a strong bearish signal per academic literature. Monitor for any upcoming corporate events (e.g., clinical trial results or regulatory decisions) that could provide context for the sales. The pattern of sequential daily sales by the CEO may indicate a pre-arranged 10b5-1 plan; if not, further sales could warrant attention.

Key Facts

  • CEO Roger Jeffs sold 100,000 shares across May 20-26, 2026, totaling ~$6.1M.
  • Director/10% owner Caligan Partners LP sold 5,300 shares on May 19, 2026, for ~$318K.
  • Total insider sales of ~$6.4M equal 0.12% of LQDA's $5.4B market cap.
  • No open-market insider purchases occurred in the cluster.

Financial Impact

Insider sales of $6.4M, 0.12% of market cap

Risk Factors

  • If the CEO's sales are not part of a 10b5-1 plan, continued selling could signal management's view of overvaluation.
  • Caligan Partners' sale reduces a major holder's stake, but the amount is small.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (15 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LQDA-1779833830589
32 reports for LQDA
Performance horizon
82% Hit rate 9 of 11 directional calls best @ T+60▲ +70.18%Mar 5, 2026
Filters
Rows
Reports for LQDA — sortable, filterable
Type Now
Jun 11, 2026
1d ago
Institutional Cluster
BULLISH ★ 5/10
$65.50 awaiting T+1awaiting T+1$71.23 (+8.75%)
Jun 10, 2026
2d ago
144
BEARISH ★ 5/10
$65.21 awaiting T+1awaiting T+1$71.23 (−9.23%)
Jun 8, 2026
4d ago
Insider Cluster
NEUTRAL ★ 3/10
$63.94 awaiting T+1awaiting T+1$71.23 (+11.40%)
Jun 8, 2026
4d ago
CLUSTER / 8-K
NEUTRAL ★ 5/10
$63.94 awaiting T+1awaiting T+1$71.23 (+11.40%)
Jun 4, 2026
8d ago
144
BEARISH ★ 6/10
$62.76 awaiting T+1awaiting T+1$71.23 (−13.50%)
Jun 4, 2026
8d ago
144
BEARISH ★ 5/10
$62.76 awaiting T+1awaiting T+1$71.23 (−13.50%)
Jun 3, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
$62.54 $61.85▼ −1.10%▲ +1.50%$71.23 (+13.90%)
Jun 1, 2026
11d ago
144
NEUTRAL ★ 4/10
$58.75 $55.11▼ −6.20%▼ −6.34%$71.23 (+21.24%)
May 26, 2026
17d ago
Insider Cluster
NEUTRAL ★ 4/10
$62.03 $62.03· 0.00%▼ −0.55%$71.23 (+14.83%)
May 21, 2026
23d ago
Insider Cluster
MIXED ★ 5/10
$61.97 $60.98▼ −1.60%▼ −2.04%$71.23 (+14.94%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (50h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access